enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
3.390
+0.040 (1.19%)
Nov 4, 2024, 4:00 PM EST - Market closed
enVVeno Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | - | - | - | - | - | 0.03 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -83.25% | Upgrade
|
| Gross Profit | - | - | - | - | - | 0.03 | Upgrade
|
| Selling, General & Admin | 11.69 | 11.66 | 15.02 | 11.17 | 4.88 | 4.91 | Upgrade
|
| Research & Development | 11.72 | 13.58 | 9.91 | 5.73 | 4.25 | 2.21 | Upgrade
|
| Operating Expenses | 23.41 | 25.24 | 24.93 | 16.89 | 9.14 | 7.12 | Upgrade
|
| Operating Income | -23.41 | -25.24 | -24.93 | -16.89 | -9.14 | -7.09 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0 | Upgrade
|
| Interest & Investment Income | 0.28 | 0.18 | 0.16 | 0.02 | 0 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.03 | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | -23.13 | -25.06 | -24.77 | -16.84 | -9.14 | -7.04 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.89 | 1.54 | 0.1 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.59 | Upgrade
|
| Other Unusual Items | - | - | - | 0.31 | - | - | Upgrade
|
| Pretax Income | -21.24 | -23.52 | -24.67 | -16.53 | -9.14 | -7.63 | Upgrade
|
| Earnings From Continuing Operations | -21.24 | -23.52 | -24.67 | -16.53 | -9.14 | -7.63 | Upgrade
|
| Net Income | -21.24 | -23.52 | -24.67 | -16.53 | -9.14 | -7.63 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.61 | - | Upgrade
|
| Net Income to Common | -21.24 | -23.52 | -24.67 | -16.53 | -9.74 | -7.63 | Upgrade
|
| Shares Outstanding (Basic) | 16 | 12 | 9 | 9 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 12 | 9 | 9 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 68.13% | 29.87% | 9.12% | 572.10% | 104.86% | 68.34% | Upgrade
|
| EPS (Basic) | -1.33 | -1.91 | -2.60 | -1.90 | -7.54 | -12.10 | Upgrade
|
| EPS (Diluted) | -1.33 | -1.91 | -2.60 | -1.90 | -7.54 | -12.10 | Upgrade
|
| Free Cash Flow | -16.74 | -18.89 | -15.73 | -12.22 | -7.86 | -6.26 | Upgrade
|
| Free Cash Flow Per Share | -1.05 | -1.54 | -1.66 | -1.41 | -6.08 | -9.93 | Upgrade
|
| Gross Margin | - | - | - | - | - | 100.00% | Upgrade
|
| Operating Margin | - | - | - | - | - | -22681.85% | Upgrade
|
| Profit Margin | - | - | - | - | - | -24406.74% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -20037.42% | Upgrade
|
| EBITDA | -23.2 | -25.02 | -24.72 | -16.74 | -9.04 | -6.96 | Upgrade
|
| D&A For EBITDA | 0.2 | 0.22 | 0.21 | 0.15 | 0.1 | 0.12 | Upgrade
|
| EBIT | -23.41 | -25.24 | -24.93 | -16.89 | -9.14 | -7.09 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.